English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Objective: To evaluate Katona’s neurorehabilitation therapy in preterm and term infants with risk factors for brain damage followed up to 24 months of age. Methods: 262 infants from 25 to 40 weeks of gestational age (GA) were treated with neurohabilitation beginning before 2 months of corrected age. Treatment was intensive, sustained for at least 12 months and required family participation. Neuropediatric examinations, MRI and Bayley-II scales were performed. Results: Abnormal MRI findings were observed in 80% of infants (increase in lateral ventricle volumes, decrease in corpus callosum volume, diffuse and cystic periventricular leukomalacia, diffuse white matter abnormalities, haemorrhages, infarcts). Outcome: Bayley-II scales showed that 20% of infants with a GA of less than 29 weeks and less than 15% of infants with a 30-40 week GA had significantly delayed MDI and PDI scores. Conclusion: Diagnosis and treatment using neurohabilitation in new-borns at risk of brain damage is recommended.

Outcome of Infants at Risk of Brain Damage after Katona Neurohabilitation Therapy